Prevention of abnormal scarring in woundhealing

S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention

of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Neurons: How RNA granules grow and shrink

LMU scientists have shown that small aggregates function as temporary RNA repositories, which are regulated by neural activity. Cells constantly have to adapt the level of activity of certain genes…

Custom ‘headphones’ boost atomic radio reception 100-fold

Researchers at the National Institute of Standards and Technology (NIST) have boosted the sensitivity of their atomic radio receiver a hundredfold by enclosing the small glass cylinder of cesium atoms…

New tech aims to drive down costs of hydrogen fuel

Researchers from North Carolina State University have developed a new technique for extracting hydrogen gas from liquid carriers which is faster, less expensive and more energy efficient than previous approaches….

Partners & Sponsors